Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
The Oncologist|August 23, 2020
Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal CanalGrace Lee, Daniel W Kim, Vinayak Muralidhar, et al.
Cancers|March 28, 2026
Initial Evaluation of Feasibility and Cutaneous Toxicity of Electron FLASH Radiotherapy Using a Standard-of-Care Fractionation Scheme in a Porcine Skin ModelElise Konradsson, Kevin Liu, Safee Baig, et al.
Cancer Immunology Research|June 7, 2014
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockadeZachary A Cooper, Vikram R Juneja, Peter T Sage, et al.
Clinical and Translational Radiation Oncology|September 23, 2024
Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanomaSydney A Keatts, Aya F Salem, David M Swanson, et al.
Advances in Radiation Oncology|July 26, 2017
Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529Devarati Mitra, Theodore S Hong, Nora Horick, et al.
The Oncologist|October 31, 2018
Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal MalignanciesDevarati Mitra, Jeffrey W Clark, Helen A Shih, et al.
Practical Radiation Oncology|December 11, 2025
Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiation Therapy for Primary Cutaneous MelanomaNoel X Yang, Gianna L Rosamilia, Andrew J Arifin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 9, 2022
Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent ChordomaAndrew J Bishop, Behrang Amini, Heather Lin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 2, 2023
Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomesSamuel Cass, Brandon Cope, Andrew J Bishop, et al.
Practical Radiation Oncology|January 24, 2026
Outcomes Following Combined Modality Treatment to the Primary Site in Select Patients With Metastatic Soft Tissue SarcomaAndrew J Arifin, Andrew J Bishop, Devarati Mitra, et al.
Pageof 7